New semi-transparent patch delivers effective treatment for tinnitus

Revolutionary, non-surgical EU approved medical device is delivering effective treatment for tinnitus in the form of a semi-transparent patch

Sufferers of tinnitus - an uncontrollable ringing in the ears - are getting some golden silence as Swedish scientists reveal a new treatment for the condition.

The Antinitus medical device patch has received European Regulatory approval with a medical device CE Mark certifying the product's safety and clinical efficacy.

Antinitus, (Antinitus.com), is a self-administered tinnitus treatment that patients can manage themselves and easily integrate into their busy lives.

The treatment involves a 21-day course, and is delivered through a discrete semi-invisible patch which is placed behind the ear every day during the treatment.

Independent clinical studies performed at the Karolinska Trial Alliance / Karolinska Institute and the Sickla ÖNH-centre in Sweden have shown remarkable results for the first-in-class tinnitus product.

In one such clinical trial, reduction in tinnitus severity was achieved by 50% of people at end of the 3-week treatment period, and by 90% at a follow-up assessment 4 weeks after the end of therapy.

In another study 100 patients took part. Patients were required to have suffered from tinnitus for at least 4 weeks before the start of the study.

Treatment with the Antinitus patch for three weeks resulted in a significant decrease in the TSQ* scores from baseline, (P < 0.01). The TSQ score remained decreased at follow-up four weeks after the end of treatment indicating relief from the tinnitus burden. *Tinnitus severity questionnaire.

Added to this are the hugely positive results coming through the Antinitus.com website via a first of its kind post-market-follow-up survey.

Dr. Peter Åhnblad, MD, ENT Senior Consultant Head of Stockholm-Sickla Ear, Nose and Throat Center, Sweden added: "The Antinitus patch is a product that can ultimately give tinnitus patients a more lasting relief of their symptoms."

Source:

Akloma Tinnitus AB

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Early radiosurgery for small cranial nerve tumors can prevent future complications